Smyrna, GA, United States
Ucb, Inc recalls
1 recall recorded since 2018, most recently on 18 July 2019. None are listed as ongoing. Status and classification are as published by the FDA.
Recalls1
Ongoing (FDA)0
Terminated or completed1
Class I (FDA)0
Terminated Class II Drugs
- Recall started
- 18 July 2019
- Terminated
- 24 January 2020
- Reason
- Failed Dissolution Specifications.
- Distribution
- TN
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-1838-2019
- Keppra (levetiracetam) 1000 mg tablets, 60 tablets per bottle, Rx only, Manufactured for UCB, Inc. Smyrna, GA 30080, NDC 50474-597-66.
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.